1. Home
  2. IHT vs COCP Comparison

IHT vs COCP Comparison

Compare IHT & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InnSuites Hospitality Trust Shares of Beneficial Interest

IHT

InnSuites Hospitality Trust Shares of Beneficial Interest

HOLD

Current Price

$1.83

Market Cap

15.2M

Sector

Finance

ML Signal

HOLD

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$0.94

Market Cap

14.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IHT
COCP
Founded
1971
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.2M
14.1M
IPO Year
1995
2011

Fundamental Metrics

Financial Performance
Metric
IHT
COCP
Price
$1.83
$0.94
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
294.1K
56.5K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
1.77%
N/A
EPS Growth
N/A
54.65
EPS
N/A
N/A
Revenue
$7,600,000.00
$12,712,091.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.33
N/A
52 Week Low
$0.95
$0.86
52 Week High
$4.24
$2.19

Technical Indicators

Market Signals
Indicator
IHT
COCP
Relative Strength Index (RSI) 59.96 38.30
Support Level $1.34 $0.91
Resistance Level $1.90 $1.09
Average True Range (ATR) 0.19 0.03
MACD -0.01 -0.00
Stochastic Oscillator 90.00 10.71

Price Performance

Historical Comparison
IHT
COCP

About IHT InnSuites Hospitality Trust Shares of Beneficial Interest

InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns interests in two hotels, operates and provides management services, and provides trademark license services, for two hotels. The Trust also holds an investment related to clean energy electricity generation technology and manages an option to acquire an investment in an independent boutique hotel reservation and hotel services business.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

Share on Social Networks: